Free Trial

Q2 EPS Estimates for SelectQuote Boosted by Noble Financial

SelectQuote logo with Finance background

SelectQuote, Inc. (NYSE:SLQT - Free Report) - Equities researchers at Noble Financial upped their Q2 2025 earnings per share (EPS) estimates for shares of SelectQuote in a report issued on Tuesday, November 5th. Noble Financial analyst M. Kupinski now anticipates that the company will post earnings of $0.09 per share for the quarter, up from their previous forecast of $0.07. The consensus estimate for SelectQuote's current full-year earnings is ($0.16) per share. Noble Financial also issued estimates for SelectQuote's Q3 2025 earnings at $0.06 EPS and FY2026 earnings at $0.12 EPS.

Several other research firms have also recently commented on SLQT. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $4.00 price target on shares of SelectQuote in a report on Tuesday, October 29th. Craig Hallum began coverage on SelectQuote in a research report on Monday, September 30th. They issued a "buy" rating and a $4.50 target price for the company.

Get Our Latest Research Report on SelectQuote

SelectQuote Stock Performance

Shares of NYSE:SLQT traded up $0.17 on Wednesday, hitting $2.35. 2,461,860 shares of the company were exchanged, compared to its average volume of 1,031,589. The company's 50 day moving average price is $2.43 and its two-hundred day moving average price is $2.82. The firm has a market capitalization of $402.09 million, a price-to-earnings ratio of -8.38 and a beta of 1.06. The company has a debt-to-equity ratio of 2.36, a quick ratio of 6.84 and a current ratio of 6.66. SelectQuote has a one year low of $1.03 and a one year high of $4.46.

SelectQuote (NYSE:SLQT - Get Free Report) last announced its earnings results on Monday, November 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.08). SelectQuote had a negative return on equity of 15.00% and a negative net margin of 3.45%. The company had revenue of $292.26 million for the quarter, compared to the consensus estimate of $275.15 million. During the same period last year, the firm posted ($0.19) EPS.

Institutional Trading of SelectQuote

Several institutional investors have recently bought and sold shares of SLQT. Jacobs Levy Equity Management Inc. grew its position in SelectQuote by 229.3% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,161,593 shares of the company's stock worth $2,323,000 after acquiring an additional 808,850 shares during the last quarter. Renaissance Technologies LLC grew its holdings in shares of SelectQuote by 6.5% during the second quarter. Renaissance Technologies LLC now owns 726,997 shares of the company's stock worth $2,007,000 after purchasing an additional 44,397 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of SelectQuote by 14.1% in the second quarter. Bank of New York Mellon Corp now owns 472,849 shares of the company's stock valued at $1,305,000 after buying an additional 58,481 shares in the last quarter. Panagora Asset Management Inc. raised its holdings in shares of SelectQuote by 85.5% in the second quarter. Panagora Asset Management Inc. now owns 410,009 shares of the company's stock valued at $1,132,000 after buying an additional 189,029 shares during the last quarter. Finally, KCM Investment Advisors LLC acquired a new position in SelectQuote during the 3rd quarter worth about $608,000. Institutional investors and hedge funds own 34.59% of the company's stock.

SelectQuote Company Profile

(Get Free Report)

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.

Featured Articles

Earnings History and Estimates for SelectQuote (NYSE:SLQT)

Should you invest $1,000 in SelectQuote right now?

Before you consider SelectQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.

While SelectQuote currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines